110 related articles for article (PubMed ID: 19007969)
1. Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability.
Skretting G; Lien T; Sandset PM; Iversen N
Thromb Res; 2009 Apr; 123(6):851-5. PubMed ID: 19007969
[TBL] [Abstract][Full Text] [Related]
2. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
3. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
Brodin E; Iversen N; Hansen JB
J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
[TBL] [Abstract][Full Text] [Related]
4. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.
Amini Nekoo A; Iles D
Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693
[TBL] [Abstract][Full Text] [Related]
5. Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro.
Thyzel E; Kohli S; Siegling S; Prante C; Kleesiek K; Götting C
Thromb Res; 2007; 119(6):785-91. PubMed ID: 16919311
[TBL] [Abstract][Full Text] [Related]
6. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells.
Zhao Y; Zhou S; Heng CK
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1645-50. PubMed ID: 17463335
[TBL] [Abstract][Full Text] [Related]
7. Crucial roles of GATA-2 and SP1 in adrenomedullin-affected expression of tissue factor pathway inhibitor in human umbilical vein endothelial cells exposed to lipopolysaccharide.
Liu W; Zhu ZQ; Wang W; Zu SY; Zhu GJ
Thromb Haemost; 2007 May; 97(5):839-46. PubMed ID: 17479196
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI.
Moatti D; Seknadji P; Galand C; Poirier O; Fumeron F; Desprez S; Garbarz M; Dhermy D; Arveiler D; Evans A; Luc G; Ruidavets JB; Ollivier V; Hakim J; Aumont MC; de Prost D
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):862-9. PubMed ID: 10195910
[TBL] [Abstract][Full Text] [Related]
9. [Expression and purification of tissue factor pathway inhibitor in Pichia pastoris].
Luo SP; Song LP; Yu B; Zhang HL; Liu LX; Leng XG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):222-7. PubMed ID: 17536273
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance.
Wu J; Stevenson MJ; Brown JM; Grunz EA; Strawn TL; Fay WP
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):698-704. PubMed ID: 18276908
[TBL] [Abstract][Full Text] [Related]
12. [Influence of human tissue factor pathway inhibitor gene transfection on neointima formation in vein grafts].
Li Q; Zhang K; Jiang X; Sun T; Wu L; Zhou C; Chen S
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):354-8. PubMed ID: 18396721
[TBL] [Abstract][Full Text] [Related]
13. Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta.
Chinni E; Colaizzo D; Margaglione M; Rubini C; D'Ambrosio RL; Giuliani F; Di Vagno G; Grandone E
Thromb Res; 2008; 122(3):376-82. PubMed ID: 18342915
[TBL] [Abstract][Full Text] [Related]
14. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
Westmuckett AD; Kakkar VV; Hamuro T; Lupu F; Lupu C
Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
[TBL] [Abstract][Full Text] [Related]
15. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombotic mechanisms of holothurian glycosaminoglycan extracted from sea cucumber].
Shen WZ; Zhou RF; Wang XF; Ding QL; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):579-83. PubMed ID: 17278421
[TBL] [Abstract][Full Text] [Related]
17. Heparanase, tissue factor, and cancer.
Nadir Y; Vlodavsky I; Brenner B
Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
[TBL] [Abstract][Full Text] [Related]
18. A del T poly T (8) mutation in the 3' untranslated region (UTR) of the CDK2-AP1 gene is functionally significant causing decreased mRNA stability resulting in decreased CDK2-AP1 expression in human microsatellite unstable (MSI) colorectal cancer (CRC).
Shin J; Yuan Z; Fordyce K; Sreeramoju P; Kent TS; Kim J; Wang V; Schneyer D; Weber TK
Surgery; 2007 Aug; 142(2):222-7. PubMed ID: 17689689
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
Lwaleed BA; Bass PS
J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
[TBL] [Abstract][Full Text] [Related]
20. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
